Crystalline forms of deuterium-enriched pioglitazone | Patent Number 11319313

US 11319313 B2
Application Number17314538
Publication NumberUS 20210403464 A1
Pendency12 months, 1 day
Filled DateMay 7, 2021
Priority DateJun 30, 2020
Publication DateDec 30, 2021
Expiration DateJun 29, 2040
Inventor/ApplicantsLaure Francoise Valerie Navarre
Vincent Jacques
Sheila DeWitt
Sebastien Bolze
Emeline Gardette
ExaminesSAMALA, JAGADISHWAR RAO
Art Unit1618
Technology Center1600
Assignments
Pixel Law
Current
Pixel Law
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.